𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A promising therapeutic vaccination to suppress hepatitis B virus replication in immunosuppressed patients

✍ Scribed by Michio Imawari

Book ID
106179568
Publisher
Springer Japan
Year
2004
Tongue
English
Weight
76 KB
Volume
39
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Host sphingolipid biosynthesis is a prom
Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication
✍ Kanako Tatematsu; Yasuhito Tanaka; Masaya Sugiyama; Masayuki Sudoh; Masashi Mizo πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 528 KB

Serine palmitoyltransferase (SPT) catalyzes the first step in the sphingolipid biosynthetic pathway. Myriocin inhibits SPT and was shown to suppress the replication of hepatitis C virus (HCV) in vitro and in vivo. However, its effect on hepatitis B virus (HBV) replication is unknown. In this study,

Strategies to prevent hepatitis B virus
Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy
✍ Chiun Hsu; Shu-Chen Wei; Ann-Lii Cheng; Pei-Jer Chen πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 52 KB

prednisone at 50 mg/day and azathioprine at 50 mg/day was initiated. Of note, liver function tests (LFTs) were normal at this time. Two weeks later, the patient was well, prednisone was completely tapered, and azathioprine was increased to 100 mg/day. Three months later, the patient presented to the